Difference between revisions of "ELOC-mutated renal cell carcinoma"

Jump to navigation Jump to search
m
Line 116: Line 116:
NEGATIVE: CK34betaE12, CK20.
NEGATIVE: CK34betaE12, CK20.


The staining and morphology raises the possibility of a ELOC-mutated renal cell carcinoma (RCC).
The differential diagnosis includes: (1) clear cell renal cell carcinoma, (2) RCC with a mTOR pathway mutation, and (3) ELOC-mutated RCC.


The differential diagnosis includes: (1) RCC with a mTOR pathway mutation, and (2) ELOC-mutated RCC.
Clear cell renal cell carcinoma is not excluded.
</pre>
</pre>